New NMN Group Standard

Author: GSHWORLD Release time: 2024-06-26 Column: Company News

With the continuous improvement of health awareness, β-Nicotinamide Mononucleotide (NMN), as a star product in the health field, has attracted widespread attention from consumers around the world.

Recently, the group standard T/CCCMHPIE 1.99-2024 "Technical Requirements for Quality of Cross-border Products of β-nicotinamide mononucleotide" drafted by GSH BIO-TECH was officially released and will be implemented on July 1, which marks a new milestone in the quality and safety standards of NMN products.

The standard sets the quality requirements, production and processing requirements, test methods, inspection rules, labeling, packaging, storage and transportation of cross-border products of β-nicotinamide mononucleotide (β-NMN), and is applicable to cross-border products made of β-nicotinamide mononucleotide as raw materials.

As a professional API raw material manufacturer, GSH BIO-TECH is well aware of the importance of product quality. In the process of formulating this standard, we provided strong technical support and practical guidance for the formulation of the standard with our rich experience and technical accumulation.

NMN powder

The release of this standard not only improves the overall quality level of NMN products, but also provides strong support for the standardization and standardization of the entire health product industry.

GSH BIO-TECH has always adhered to green environmental protection, technological innovation and global layout. The company is equipped with advanced scientific research equipment and an experienced scientific research team, and continuously strengthens product research and development and technological innovation. In the future, we will continue to participate in the formulation and improvement of industry standards and contribute to the healthy development of the industry.

Tag: NMN